Glenmark Pharma.

GLENMARK27 May 2024
Pharmaceuticals
0.00 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Glenmark Pharma.
Glenmark Pharma.
Pharmaceuticals
GLENMARK27 May 2024
0.00 (0.00%)
1D
1M
6M
1Y
5Y
All

Glenmark Pharma. - Share Price & Details

Lowest Today
1031.25
Highest Today
1124.5
Today’s Open
1031.25
Prev. Close
1119.45
52 Week High
1124.5
52 Week Low
581
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
88.30%
Upper Circuit
Lower Circuit
P/E TTM
22.19
P/B Ratio
1.38
Traded Value(Cr)
0.00
EPS TTM
50.49
Book value
Dividend
0.22%

Price Performance

8.22 %
1 Wk
4.51 %
1 M
20.68 %
3 M
88.30 %
1 Y
30.83 %
YTD

Traded Volume Movement

Technical Details

Support 3
966
Support 2
999
Support 1
1059
Pivot Point :
1092
Resistance 1
1153
Resistance 2
1185
Resistance 3
1246

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Glenmark Pharmaceuticals Ltd
₹1,119.45(0.00/0.00%)
1,119.45+0.0031,589.5588.3022.191.38
Lupin Ltd
₹1,616.10(0.00/0.00%)
1,616.10+0.0073,653.77100.5831.653.57
Ipca Laboratories Ltd
₹1,296.60(0.00/0.00%)
1,296.60+0.0032,895.2988.1659.725.30
1,782.05+0.0027,657.6869.5850.899.58
Sanofi India Ltd
₹8,673.75(0.00/0.00%)
8,673.75+0.0019,975.6527.2935.1919.67
369.75+0.002,170.64-16.5516.031.35

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 31613.54 crores. It has reported a sales of Rs. 2077.13 crores and a net profit of Rs. 4613.7 crores for the quarter ended December 2018. The company management includes Glenn Saldanha, Glenn Saldanha,Cheryl Pinto,V S Mani,B E Saldanha,Rajesh Desai.,Devendra Raj Mehta,Bernard Munos,Brian W Tempest,Sridhar Gorthi,Sona Saira Ramasastry,Dipankar Bhattacharjee,V R Iyer (Glenmark Pharmaceuticals Ltd) among others.
Chairman
Glenn Saldanha
Registered office
B/2 Mahalaxmi Chambers,22 Bhulabhai Desai Road,Mumbai,Maharashtra,400026
FAX :91-22-40189986
Background
Incorporation Year1977
Face Value₹1
Market Lot1

Latest News

What to expect from Indian stock market in trade on May 28?
The Indian stock market benchmark indices, 📉Sensex and 📉Nifty 50, are likely to open flat on Tuesday following mixed global cues. The trends on Gift Nifty also indicate a flat-to-positive start for the Indian benchmark index. The Gift Nifty was trading around 23,020 level, a premium of nearly 20 points from the Nifty futures’ previous close.
28 May 2024 | 08:53 AM
What to expect from Indian stock market in trade on May 28?
The Indian stock market benchmark indices, 📉Sensex and 📉Nifty 50, are likely to open flat on Tuesday following mixed global cues. The trends on Gift Nifty also indicate a flat-to-positive start for the Indian benchmark index. The Gift Nifty was trading around 23,020 level, a premium of nearly 20 points from the Nifty futures’ previous close.
28 May 2024 | 08:53 AM
Trade Spotlight: Strategies for Tuesday's market on top stocks and others
📌Prudent Corporate Advisory Services | CMP: Rs 1,730
📌Hindustan Petroleum Corp. | CMP: Rs 557
📌Gravita | CMP: Rs 1,139
📌Exide Industries | CMP: Rs 494
📌Reliance Industries | CMP: Rs 2,932.5
📌UltraTech Cement | CMP: Rs 10,225.5
📌Axis Bank | CMP: Rs 1,187
📌JBM Auto | CMP: Rs 2,117
📌Automotive Stampings & Assemblies | CMP: Rs 896.55
📌Paras Defence & Space Tech. | CMP: Rs 894.7
28 May 2024 | 09:10 AM
Trade setup for today: Things to know before opening bell
Before market opens on Tue, check these things: 📌Key Levels For Nifty 50📌Key Levels For BANK Nifty📌Nifty Call Options Data 📌Nifty Put Options Data📌Bank Nifty Call Options Data 📌Bank Nifty Put Options Data📌Put-Call Ratio 📌India VIX 📌Long Buildup (47 Stocks)📌Long Unwinding (36 Stocks) 📌 Short Build-up (44 Stocks) 📌Short-Covering (59 Stocks) 📌High Delivery Trades 📌Stocks Under F&O Ban.
28 May 2024 | 09:00 AM
Pre-market action: Here's the trade setup for today's session
📌GIFT Nifty (Earlier SGX Nifty) signals a muted start.
📌The dollar waned on Tuesday following a slight pick up in risk appetite.
📌FIIs were net sellers of Indian equities on Monday as they sold shares worth Rs 541.22 crore.
📌With the Q4 earnings season nearing its last leg, a host of companies, including IRCTC, and AB Fashion are set to declare their March quarter results on Tuesday.
28 May 2024 | 08:56 AM

How to buy Glenmark Pharma. shares on nse?

To buy Glenmark Pharma. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Glenmark Pharma. share price today?

The Glenmark Pharma. shares price on nse is Rs.1119.45 today.

What is the market cap of Glenmark Pharma. shares on NSE ?

The company has a market capitalization of Rs.31589.55Cr

What is the PE & PB ratio of Glenmark Pharma. shares ?

PE is 22.19 and PB is 1.38

What is the 52 Week High and Low of Glenmark Pharma. shares?

Glenmark Pharma. stock price high: Rs.1124.5 Glenmark Pharma. stock price low: Rs.581

How has the GLENMARK share price performed in the past year?

In April 2022, the huge pharmaceutical GLENMARK’s share price was in the region of Rs. 478. By June, it had dipped to the late 300 levels and never significantly went up till November. Highs were felt in December, and February 2023, and now the stock is at the 448 level. 

Does GLENMARK pay dividends to its shareholders?

GLENMARK has a consistent track record of paying dividends to its loyal shareholders. In the recent past, the company has paid only final dividends, but interim dividends have been paid in the past as well. 

What is the dividend yield of GLENMARK?

The dividend yield of GLENMARK is 0.56% (March 2022). 

How does GLENMARK compare to its competitors in terms of share price?

Compared to popular competitors of GLENMARK, like Sun Pharma, Dr Reddy’s Labs, CIPLA, Torrent Pharma, Abbott India and others, the company’s share price is low at the moment (March 2023). Most of these companies have their share prices in the thousands, or late hundreds, whereas GLENMARK seems firmly poised on the mid-hundred mark. 

What is the company's debt-to-equity ratio?

The company’s debt-to-equity ratio is 0.22. 

What is the company's revenue and net income?

The revenue of GLENMARK is Rs. 3,463 crores (Q3 FY 2022-23)  and the net income is Rs. 291 crores (December 2022). 

How long has GLENMARK been in business?

GLENMARK started its foray into the pharmaceutical business with “Candid Cream”, a key dermatological drug, even in use now. The company started its business in 1977, headed by its Founder Emeritus, the late Gracias Saldanha. 

What is the company's history of share price performance?

The share price of GLENMARK has been somewhat stable in the last 4-5 years, not showing much volatility as other pharma stocks have. In 2018, the share was in the region of the 500 mark, peaking at nearly 700 in 2019. Then, with a gradual and slow downward movement, it dipped to the region of 199 in 2020, only to slowly rise to 662 in 2021. Since then, it has been in the range of between 400-500 and is steady now.